The 58 references in paper Ж Кобалава Д, Ю Котовская В, И Семагина М (2017) “ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ” / spz:neicon:aterotromboz:y:2016:i:2:p:98-108

1
Agabiti-Rosei E, Mancia G, O’Rourke MF et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension,2007, 50(1): 154-160.
(check this in PDF content)
2
Roman MJ, Devereux RB, Kizer JR et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol, 2009, 54(18): 1730-1734.
(check this in PDF content)
3
Wang KL, Cheng HM, Chuang SY et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens.2009, 27(3): 461-467.
(check this in PDF content)
4
Chirinos JA, Zambrano JP, Chakko S et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension, 2005, 45(5): 980-985.
(check this in PDF content)
5
Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J, 2010, 31(15): 1865-18671.
(check this in PDF content)
6
Jankowski P, Kawecka-Jaszcz K, Czarnecka D et al.; Aortic Blood Pressure and Survival Study Group. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension, 2008, 51(4): 848-855.
(check this in PDF content)
7
Roman MJ, Devereux RB, Kizer JR et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension, 2007, 50(1): 197-203.
(check this in PDF content)
8
Safar ME, Jankowski P. Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond), 2009, 116(4): 273-282.
(check this in PDF content)
9
Boutouyrie P, Lacolley P, Briet M, Regnault V et al. Pharmacological modulation of arterial stiffness. Drugs, 2011, 71(13): 1689-1701.
(check this in PDF content)
10
Williams B, Lacy PS, Thom SM et al. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFГ Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation,2006, 113(9): 1213-125.
(check this in PDF content)
11
Safar ME, Blacher J, Protogerou A, Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens, 2008, 26(1): 130-137.
(check this in PDF content)
12
Hirata K, Vlachopoulos C, Adji A, O’Rourke MF. Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery? J Hypertens, 2005, 23(3): 551-556.
(check this in PDF content)
13
Dhakam Z, McEniery CM, Yasmin, CJR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens,2006, 19(2): 214-219.
(check this in PDF content)
14
Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension, 2009, 54(2): 409-413.
(check this in PDF content)
15
Koumaras C, Tzimou M, Stavrinou E et al. Role of antihypertensive drugs in arterial “de-stiffening” and central pulsatile hemodynamics. Am J Cardiovasc Drugs, 2012, 12(3): 143-156.
(check this in PDF content)
16
Manisty CH, Hughes AD. Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br. J. Clin. Pharmacol., 2013, 75: 79-92.
(check this in PDF content)
17
Fok H, Cruickshank JK. Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation? Curr Hypertens Rep,2015 Aug, 17(8): 67.
(check this in PDF content)
18
Национальные рекомендации по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза, четвертый пересмотр. Российский кардиологический журнал, 2012, 4 (Приложение 1).
(check this in PDF content)
19
ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. Journal of Hypertension, 2013, 31: 1925-1938.
(check this in PDF content)
20
Кобалава Ж.Д. Артериальная ригидность и центральное давление: новые патофизиологические и лечебные концепции. Артериальная гипертензия, 2010, 16(2): 126-133.
(check this in PDF content)
21
Потешкина Н.Г. Потребление соли, артериальная гипертензия и риск развития сердечно-сосудистых заболеваний. Российский кардиологический журнал, 2011, 5: 93-102.
(check this in PDF content)
22
Nilsson PM, Boutouyrie P, Laurent S. Vascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention. Hypertension, 2009, 54: 3-10.
(check this in PDF content)
23
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P et al. for the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 2006, 27: 2588-2605.
(check this in PDF content)
24
London GM, Asmar RG, O’Rourke MF, Safar ME. REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol, 2004, 43(1): 92-99.
(check this in PDF content)
25
Vlachopoulos C, Hirata K, O’Rourke MF. Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections. Hypertension, 2001, 38(6): 1456-1460.
(check this in PDF content)
26
Briet M, Schiffrin EL. Treatment of arterial remodeling in essential hypertension. Curr Hypertens Rep, 2013 Feb, 15(1): 3-9.
(check this in PDF content)
27
Cameron JD, Asmar R, Struijker-Boudier H, Shirai K et al. Current and future initiatives for vascular health management in clinical practice. Vasc Health Risk Manag, 2013, 9: 255-264.
(check this in PDF content)
28
Dudenbostel T, Glasser SP. Effects of antihypertensive drugs on arterial stiffness. Cardiol Rev, 2012 Sep-Oct, 20(5): 259-263.
(check this in PDF content)
29
Jekell A, Malmqvist K, WallОn NH, MЪrtsell D, Kahan T. Markers of inflammation, endothelial activation and arterial stiffness in hypertensive heart disease, and the effects of treatment: Results from the SILVHIA study. J Cardiovasc Pharmacol, 2013 Sep, 30.
(check this in PDF content)
30
Koumaras C, Tziomalos K, Stavrinou E, Katsiki N et al. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens, 2013 Oct, 16.
(check this in PDF content)
31
Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens, 2004, 17: 118-123.
(check this in PDF content)
32
Pannier BM, Guerin AP, Marchais SJ, London G. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol, 2001, 28: 1074-1077.
(check this in PDF content)
33
Safar ME, Laurent SL, Bouthier JD, London GM, Mimran AR. Effect of converting enzyme inhibitors on hypertensive large arteries in humans. J Hypertens, 1986, 4: 285-289.
(check this in PDF content)
34
Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension: hypertension highlights. Hypertension,2007, 49: 12021206.
(check this in PDF content)
35
Tropeano Al, Boutourie P, Pannier B et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-cjnverting enzyme inhibition in diabetic hypertensives. Hypertension, 2006, 48: 80-86.
(check this in PDF content)
36
Asmar RG, London GM, O’Rourke ME, Safar ME, REASON Project Coordinators, Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension,2001, 38: 922-926.
(check this in PDF content)
37
Kelly R, Daley J, Avolio A et al. Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension, 1989, 14(1): 14-21.
(check this in PDF content)
38
Dhakam Z, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens, 2008, 26: 351-356.
(check this in PDF content)
39
PolЧnia J, Barbosa L, Silva JA et al. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood Press Monit., 2010, 15(5): 235-239.
(check this in PDF content)
40
Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol not atenolol reduces wave reflection. Am. J. Hypertens, 2008, 21: 663-667.
(check this in PDF content)
41
Shah NK, Smith SM, Nichols WW. Carvedilol reduces aortic wave reflection and improves leftventricular/vascularcoupling: acomparison with atenolol (CENTRALStudy). J. Clin. Hypertens., 2011, 13: 917-924.
(check this in PDF content)
42
Paimbo C, Malshi E, Morizzo C. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6moth open label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension. Clin. Ther., 2009, 31(12): 28732885.
(check this in PDF content)
43
Tomiyama H, Yoshida M, Yamada J. Arterial-cardiac destiffening following long-term antihypertensive treatment. Am. J. Hypertens, 2011, 24: 1080-1006.
(check this in PDF content)
44
Нечесова Т.А., Ливенцева М.М., Коробко И.Ю., Калинина Т.В.. Влияние комбинированной антигипертензивной терапии препаратом Экватор на состояние органов-мишеней у больных артериальной гипертензией. Медицинские новости, 2008, 11: 27-31.
(check this in PDF content)
45
Прокофьева Е.Б., Глезер М.Г. Жесткость артериальной стенки и показатели центральной гемодинамики на фоне длительной комбинированной антигипертензивной терапии. Кардиология, 2015, 4(55): 19-24.
(check this in PDF content)
46
Ceconi C, Fox KM, Remme WJ et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res, 2007, 73: 237-246.
(check this in PDF content)
47
Карпов Ю.А., Сорокин Е.В. Статины, эндотелий и сердечно-сосудистый риск. РМЖ, 2001, 9: 352-353.
(check this in PDF content)
48
Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol, 2002, 39: 1020-1025.
(check this in PDF content)
49
Kontopoulos AG, Athyros VG, Pehlivanidis AN, Demitriadis DS, Papageorgiou AA, Boudoulas H. Longterm treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Curr Med Res Opin, 2003, 19: 22-27.
(check this in PDF content)
50
Williams B, Lacy PS, Cruickshank JK et al. Impact of Statin Therapy on Central Aortic Pressures and Hemodynamics Principal Results of the Conduit Artery Function Evaluation-Lipid Lowering Arm (CAFE-LLA) Study. Circulation, 2009, 119: 53-61.
(check this in PDF content)
51
Manisty С, Mayet J, Tapp RJ et al., on behalf of the ASCOT Investigators. Atorvastatin Treatment Is Associated With Less Augmentation of the Carotid Pressure Waveform in Hypertension A Substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT). Hypertension,2009, 54.
(check this in PDF content)
52
Ольбинская Л.И., Боченков Ю.В, Железных Е.А. Фармакотерапия больных гипертоническоий болезнью с метаболическим синдромом. Врач, 2001, 4: 19-21.
(check this in PDF content)
53
Nissen SE, Nicholls SJ, Sipahi I et al. ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA, 2006, 295: 1556-1565.
(check this in PDF content)
54
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al., JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008, 359: 2195-2207.
(check this in PDF content)
55
Галеева З.М., Галявич А.С. Фиксированная комбинация лизиноприла с амлодипином в сочетании с розувастатином у больных гипертонической болезнью и ишемической болезнью сердца. Тер. архив, 2014; 9: 71-76.
(check this in PDF content)
56
Effectiveness and safety of combined antihypertensive and cholesterol-reducing therapy (lisinopril-amlodipine and rosuvastatin) in high and very high risk patient populations. Cardiologia Hungarica, 2015, 45: 71.
(check this in PDF content)
57
Кобалава Ж.Д., Котовская Ю.В., Семагина И.М., Богомаз А.В. Суточные профили артериального давления в плечевой артерии и аорте: соотношение и эффекты фиксированной комбинации амлодипина и лизиноприла. Кардиология, 2014, 54(10): 13-18.
(check this in PDF content)
58
Драпкина О.М., Корнеева О.Н., Зятенкова Е.В. с соавт. Розувастатин у пациентов с артериальной гипертензией и дислипидемией: влияние на микроциркуляцию и свойства пульсовой волны. Лечащий врач, 2013, 3: 1-4.
(check this in PDF content)